541540 Stock Overview
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
541540 passed our risk checks.
Solara Active Pharma Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹559.50 |
| 52 Week High | ₹606.95 |
| 52 Week Low | ₹287.00 |
| Beta | 0.87 |
| 1 Month Change | 51.05% |
| 3 Month Change | 43.81% |
| 1 Year Change | 56.13% |
| 3 Year Change | -62.67% |
| 5 Year Change | 45.82% |
| Change since IPO | 104.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| 541540 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 18.0% | -0.1% | 1.8% |
| 1Y | 56.1% | 55.9% | 46.4% |
Price Volatility
| 541540 volatility | |
|---|---|
| 541540 Average Weekly Movement | 10.0% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 2,361 | Poorvank Purohit | www.solara.co.in |
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, loop diuretic, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, topical anti-infectives, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, nucleoside inhibitor, aprepitant, NSAIDs, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support.
Solara Active Pharma Sciences Limited Fundamentals Summary
| 541540 fundamental statistics | |
|---|---|
| Market cap | ₹20.19b |
| Earnings (TTM) | -₹3.08b |
| Revenue (TTM) | ₹14.07b |
1.4x
P/S Ratio-6.5x
P/E RatioIs 541540 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 541540 income statement (TTM) | |
|---|---|
| Revenue | ₹14.07b |
| Cost of Revenue | ₹8.88b |
| Gross Profit | ₹5.19b |
| Other Expenses | ₹8.28b |
| Earnings | -₹3.08b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -85.64 |
| Gross Margin | 36.91% |
| Net Profit Margin | -21.91% |
| Debt/Equity Ratio | 67.2% |
How did 541540 perform over the long term?
See historical performance and comparison